| scholarly article | Q13442814 |
| P2093 | author name string | Marek Malecki | |
| P2860 | cites work | MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line | Q21202160 |
| Emerging concepts in the immunopathogenesis of AIDS | Q22241984 | ||
| CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors | Q24652007 | ||
| Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment | Q24656967 | ||
| The natural history of EGFR and EGFRvIII in glioblastoma patients | Q24814477 | ||
| Mucin-based targeted pancreatic cancer therapy | Q26861761 | ||
| Cancer statistics, 2010 | Q27860525 | ||
| Identification and expansion of human colon-cancer-initiating cells | Q27860627 | ||
| CD44 expression indicates favorable prognosis in epithelial ovarian cancer | Q28183827 | ||
| Efficacy of lentivirus-mediated and MUC1 antibody-targeted VP22-TK/GCV suicide gene therapy for ovarian cancer. | Q40641602 | ||
| Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system | Q40679193 | ||
| Specific CEA-producing colorectal carcinoma cell killing with recombinant adenoviral vector containing cytosine deaminase gene. | Q40741120 | ||
| The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters | Q40810330 | ||
| Neuron specific enolase promoter for suicide gene therapy in small cell lung carcinoma. | Q40813146 | ||
| Adenovirus-mediated Bax overexpression for the induction of therapeutic apoptosis in prostate cancer. | Q40825681 | ||
| Prostate-specific suicide gene therapy using the prostate-specific membrane antigen promoter and enhancer | Q40849909 | ||
| Ex-vivo evaluation of gene therapy vectors in human pancreatic (cancer) tissue slices | Q41833348 | ||
| Adenovirus-mediated tissue-targeted expression of a caspase-9-based artificial death switch for the treatment of prostate cancer | Q42510207 | ||
| CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors | Q43411083 | ||
| Characterization of the cyclooxygenase-2 promoter in an adenoviral vector and its application for the mitigation of toxicity in suicide gene therapy of gastrointestinal cancers | Q43556296 | ||
| Suicide gene therapy on LNCaP human prostate cancer cells | Q43666048 | ||
| In vivo suicide gene therapy model using a newly discovered prostate-specific membrane antigen promoter/enhancer: a potential alternative approach to androgen deprivation therapy | Q43705366 | ||
| Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model. | Q43708562 | ||
| Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954. | Q43831003 | ||
| Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing | Q43962720 | ||
| Suicide gene therapy using keratin 19 enhancer and promoter in malignant mesothelioma cells. | Q44009716 | ||
| Suicide gene therapy for prostate cancer--update of current development | Q44522976 | ||
| The CD44 Receptor Is a Molecular Predictor of Survival in Ovarian Cancer | Q44558334 | ||
| Treatment of ovarian cancer cell line Skov3 with HSV-tk/GCV under the control of human telomerase reverse transcriptase gene promoter | Q44584823 | ||
| Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model. | Q44645371 | ||
| Treatment efficiency of a suicide gene therapy using prostate-specific membrane antigen promoter/enhancer in a castrated mouse model of prostate cancer | Q44836105 | ||
| Adenoviral oncolytic suicide gene therapy for a peritoneal dissemination model of gastric cancer in mice | Q45855727 | ||
| In vivo gene transfer of a suicide gene under the transcriptional control of the carcinoembryonic antigen promoter results in bone marrow transduction but can avoid bone marrow suppression | Q45858941 | ||
| Suicide gene therapy with adenoviral delivery of HSV-tK gene for patients with local recurrence of prostate cancer after hormonal therapy | Q45866314 | ||
| Phase I trial of replication-competent adenovirus-mediated suicide gene therapy combined with IMRT for prostate cancer | Q45866747 | ||
| Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer | Q45867327 | ||
| Side effects of suicide gene therapy. | Q45870665 | ||
| HIV vector-mediated targeted suicide gene therapy for adult T-cell leukemia | Q45871562 | ||
| Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma | Q45874553 | ||
| Therapeutic effect of genetically modified human neural stem cells encoding cytosine deaminase on experimental glioma | Q45875949 | ||
| Adenovirus-mediated transfer of inducible caspases: a novel "death switch" gene therapeutic approach to prostate cancer | Q45876190 | ||
| Tumor tropism of intravenously injected human-induced pluripotent stem cell-derived neural stem cells and their gene therapy application in a metastatic breast cancer model. | Q45876898 | ||
| Transferrin lipoplex-mediated suicide gene therapy of oral squamous cell carcinoma in an immunocompetent murine model and mechanisms involved in the antitumoral response. | Q45879519 | ||
| Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells | Q45880055 | ||
| Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter | Q45885785 | ||
| CD133+CD44+ population efficiently enriches colon cancer initiating cells | Q46457938 | ||
| Development of a genetically engineered biomimetic vector for targeted gene transfer to breast cancer cells | Q47871933 | ||
| Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas | Q48926056 | ||
| Tumor regression after systemic administration of transferrin-targeted TNFalpha plasmid-dendrimer conjugates. | Q53478288 | ||
| Isolation of single, intact chromosomes from single, selected ovarian cancer cells for in situ hybridization and sequencing. | Q54334800 | ||
| Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells. | Q54359849 | ||
| Secretion of thymidine kinase to increase the effectivity of suicide gene therapy results in the loss of enzymatic activity | Q64376841 | ||
| Evaluation of the effects of androgen receptor gene trinucleotide repeats and prostate-specific antigen gene polymorphisms on prostate cancer. | Q64904715 | ||
| CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer | Q71805116 | ||
| Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens | Q80099843 | ||
| Isolation, characterization and mobilization of prostate cancer tissue derived CD133+ MDR1+ cells | Q82322235 | ||
| Overview of gene delivery into cells using HSV-1-based vectors | Q85258572 | ||
| Bystander killing effect of tymidine kinase gene-transduced adult bone marrow stromal cells with ganciclovir on malignant glioma cells | Q39673692 | ||
| Glioblastoma cells negative for the anti-CD133 antibody AC133 express a truncated variant of the CD133 protein. | Q39709460 | ||
| Side populations of glioblastoma cells are less sensitive to HSV-TK/GCV suicide gene therapy system than the non-side population | Q39743190 | ||
| Using lentiviral vectors for efficient pancreatic cancer gene therapy | Q39775324 | ||
| HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells | Q39797615 | ||
| Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer | Q39830274 | ||
| Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. | Q39880360 | ||
| Isolation and characterization of cancer stem like cells in human glioblastoma cell lines | Q39881450 | ||
| Enhanced combined tumor-specific oncolysis and suicide gene therapy for prostate cancer using M6 promoter | Q39942987 | ||
| Improved lentiviral transduction of human mesenchymal stem cells for therapeutic intervention in pancreatic cancer | Q40023771 | ||
| Development of a transferrin receptor-targeting HVJ-E vector | Q40062249 | ||
| Replication-competent adenovirus-mediated suicide gene therapy with radiation in a preclinical model of pancreatic cancer | Q40123376 | ||
| Expression of CD44v6 correlates with cell proliferation and cellular atypia in urothelial carcinoma cell lines 5637 and HT1197. | Q40443721 | ||
| Development of an inducible suicide gene system based on human caspase 8. | Q40450767 | ||
| Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomas. | Q40465928 | ||
| Adenovirus-mediated suicide SCLC gene therapy using the increased activity of the hTERT promoter by the MMRE and SV40 enhancer. | Q40467082 | ||
| Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/ 5-fluorocytosine suicide gene therapy-induced cell death in glioma cells. | Q40481710 | ||
| A neuroblastoma-selective suicide gene therapy approach using the tyrosine hydroxylase promoter. | Q40548567 | ||
| Herpes simplex virus thymidine kinase and ganciclovir suicide gene therapy for human pancreatic cancer | Q40593343 | ||
| Epidermal growth factor receptor targeting enhances adenoviral vector based suicide gene therapy of osteosarcoma | Q40634758 | ||
| Adenovirus-mediated suicide gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter induced apoptosis of ovarian cancer cell line | Q28188296 | ||
| Identification and expansion of the tumorigenic lung cancer stem cell population | Q28259332 | ||
| The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation | Q28270177 | ||
| Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5 | Q28303765 | ||
| CXCR4 expression in prostate cancer progenitor cells | Q28480904 | ||
| Using birth defects registry data to evaluate infant and childhood mortality associated with birth defects: an alternative to traditional mortality assessment using underlying cause of death statistics | Q31135734 | ||
| The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer | Q33451434 | ||
| Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy | Q33484184 | ||
| Use of genetically engineered bone marrow-derived mesenchymal stem cells for glioma gene therapy. | Q33514643 | ||
| Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting | Q33564013 | ||
| Her2-specific multivalent adapters confer designed tropism to adenovirus for gene targeting | Q33740415 | ||
| Four carcinoembryonic antigen subfamily members, CEA, NCA, BGP and CGM2, selectively expressed in the normal human colonic epithelium, are integral components of the fuzzy coat | Q33870113 | ||
| Combined MUC1-specific nanobody-tagged PEG-polyethylenimine polyplex targeting and transcriptional targeting of tBid transgene for directed killing of MUC1 over-expressing tumour cells | Q33942904 | ||
| Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect | Q34027421 | ||
| A designer biomimetic vector with a chimeric architecture for targeted gene transfer | Q34078983 | ||
| Specific targeting strategies of cancer gene therapy using a single-chain variable fragment (scFv) with a high affinity for CEA. | Q34115033 | ||
| Suicide gene therapy with Herpes simplex virus thymidine kinase and ganciclovir is enhanced with connexins to improve gap junctions and bystander effects | Q34184994 | ||
| Herpes virus fusion and entry: a story with many characters. | Q34285628 | ||
| Clinical trials of adenoviral-mediated suicide gene therapy of malignant gliomas | Q34361481 | ||
| CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients | Q34370179 | ||
| Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin. | Q34462411 | ||
| HSV-TK/GCV cancer suicide gene therapy by a designed recombinant multifunctional vector | Q34507776 | ||
| Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase. | Q34557622 | ||
| Gene expression profiling of gliomas: merging genomic and histopathological classification for personalised therapy. | Q34627868 | ||
| Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. | Q34777492 | ||
| Adaptive seamless design for an efficacy trial of replication-competent adenovirus-mediated suicide gene therapy and radiation in newly-diagnosed prostate cancer (ReCAP Trial) | Q34855696 | ||
| Incorporation of biomarker assessment in novel clinical trial designs: personalizing brain tumor treatments | Q35161909 | ||
| Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers | Q35169094 | ||
| Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells | Q35190005 | ||
| Viral therapy for glioblastoma | Q35210466 | ||
| Gene therapy for human malignant brain tumors. | Q35210470 | ||
| Future medical applications of single-cell sequencing in cancer | Q35558519 | ||
| CD44v6: a target for antibody-based cancer therapy | Q35648600 | ||
| Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector | Q35696378 | ||
| In vitro and in vivo double-enhanced suicide gene therapy mediated by generation 5 polyamidoamine dendrimers for PC-3 cell line | Q35768818 | ||
| Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas | Q35827956 | ||
| Clinical characteristics and outcomes of BRCA-associated ovarian cancer: genotype and survival | Q35914568 | ||
| Identification of factors important for the success of suicide gene therapy after a comparative study of Varicella zoster and Herpes simplex viral thymidine kinases efficacy on breast cancer cells. | Q36261074 | ||
| Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas | Q36367428 | ||
| OVARIAN CANCER SUICIDE GENE THERAPY WITH GENETICALLY ENGINEERED, TRANSGENICALLY EXPRESSED, INTRACELLULAR scFv ANTIBODIES AGAINST ANTI-OXIDATIVE ENZYMES. | Q36460902 | ||
| TRA-1-60(+), SSEA-4(+), Oct4A(+), Nanog(+) Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the Ovaries | Q36503165 | ||
| In vivo gene transfer targeting in pancreatic adenocarcinoma with cell surface antigens | Q36536212 | ||
| Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo | Q37096766 | ||
| Molecularly targeted therapies for malignant gliomas. | Q37107374 | ||
| Targeted therapies for malignant glioma: progress and potential. | Q37159549 | ||
| CD133 expression associated with poor prognosis in ovarian cancer | Q37373712 | ||
| The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients | Q37475929 | ||
| Glioblastoma stem cells | Q37831190 | ||
| Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review. | Q38022486 | ||
| In vivo characterization of a prostate-specific antigen promoter-based suicide gene therapy for the treatment of benign prostatic hyperplasia | Q38520136 | ||
| Human embryonic stem cell-derived mesenchymal stem cells as cellular delivery vehicles for prodrug gene therapy of glioblastoma | Q38888896 | ||
| The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cells | Q39084406 | ||
| Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases | Q39111100 | ||
| Glioma gene therapy using induced pluripotent stem cell derived neural stem cells | Q39166287 | ||
| Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell. | Q39335846 | ||
| Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma | Q39360531 | ||
| Bystander effect in suicide gene therapy using immortalized neural stem cells transduced with herpes simplex virus thymidine kinase gene on medulloblastoma regression | Q39370389 | ||
| Bystander killing of malignant cells via the delivery of engineered thymidine-active deoxycytidine kinase for suicide gene therapy of cancer. | Q39386066 | ||
| Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion | Q39413746 | ||
| Suicidal gene therapy against tumor using reducible poly (oligo-D-arginine). | Q39423134 | ||
| Selective killing of lung cancer cells using carcinoembryonic antigen promoter and double suicide genes, thymidine kinase and cytosine deaminase (pCEA-TK/CD). | Q39440479 | ||
| Non-integrating lentiviral vectors for specific killing of Epstein-Barr virus nuclear antigen 1-positive B cell lymphoma cells | Q39488698 | ||
| Nanoparticle-delivered VEGF-silencing cassette and suicide gene expression cassettes inhibit colon carcinoma growth in vitro and in vivo | Q39506352 | ||
| Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma | Q39512141 | ||
| Targeted suicide gene therapy for glioma using human embryonic stem cell-derived neural stem cells genetically modified by baculoviral vectors. | Q39531933 | ||
| Identification and functional characterization of glioma-specific promoters and their application in suicide gene therapy | Q39586718 | ||
| Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties | Q39616065 | ||
| Non-covalent association of folate to lipoplexes: a promising strategy to improve gene delivery in the presence of serum | Q39636701 | ||
| P433 | issue | 3 | |
| P921 | main subject | gene therapy | Q213901 |
| suicide | Q10737 | ||
| P577 | publication date | 2012-10-01 | |
| P1433 | published in | Journal of genetic syndromes & gene therapy | Q27723954 |
| P1476 | title | Frontiers in Suicide Gene Therapy of Cancer | |
| P478 | volume | 2012 |
| Q38870602 | A Lentiviral Vector Expressing Desired Gene Only in Transduced Cells: An Approach for Suicide Gene Therapy |
| Q35109273 | Eradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant DNASE1, DNASE1L3, DNASE2, and DFFB Controlled by EGFR Promoter: Novel Strategy for Targeted Therapy of Cancer |
| Q37366610 | Improved Adeno-associated Viral Gene Transfer to Murine Glioma. |
| Q59357946 | Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy |
| Q38421345 | Killing of cancer cells through the use of eukaryotic expression vectors harbouring genes encoding nucleases and ribonuclease inhibitor |
| Q92081727 | LdrB Toxin with In Vitro and In Vivo Antitumor Activity as a Potential Tool for Cancer Gene Therapy |
| Q33920686 | Safeguarding Stem Cell-Based Regenerative Therapy against Iatrogenic Cancerogenesis: Transgenic Expression of DNASE1, DNASE1L3, DNASE2, DFFB Controlled By POLA1 Promoter in Proliferating and Directed Differentiation Resisting Human Autologous Plurip |
| Q33653485 | Stem cells' guided gene therapy of cancer: New frontier in personalized and targeted therapy |
| Q37347017 | Suicide Gene Therapy for Cancer - Current Strategies |
| Q35176800 | Therapeutic properties of a vector carrying the HSV thymidine kinase and GM-CSF genes and delivered as a complex with a cationic copolymer. |
| Q41040429 | Using intron splicing trick for preferential gene expression in transduced cells: an approach for suicide gene therapy |
Search more.